Myriad Genetics | MYGN - Ordinary Share Capital



Myriad Genetics reported $900K in Ordinary Share Capital for its fiscal quarter ending in March of 2025.


Ordinary Share Capital Change Date
Agilent USD 283.59M 280.59M Jul/2025
Becton, Dickinson and Co. USD 370.59M 406K Jun/2025
Bio-Rad Laboratories USD 27.06M 27.06M Jun/2025
Bruker USD 151.72M 149.92M Jun/2025
Danaher USD 715.9M 706.9M Jun/2025
Exact Sciences USD 189.22M 187.33M Jun/2025
Hologic USD 222.22M 219.22M Jun/2025
Illumina USD 154M 152M Jun/2025
J&J USD 3.12B 0 Mar/2025
Mettler Toledo International USD 20.6M 20.15M Jun/2025
Myriad Genetics USD 900K 0 Mar/2025
Quest Diagnostics USD 112M 110M Jun/2025
Quidel USD 67.7M 67.6M Jun/2025
Repligen USD 562K 1000 Mar/2025
Revvity USD 117.87M 2.78M Jun/2025
Standard Biotools USD 381.69M 381.3M Jun/2025
Thermo Fisher Scientific USD 377.49M 66.51M Jun/2025
Veracyte USD 78.32M 78.24M Jun/2025
Waters USD 59.51M 57.88M Jun/2025